L3Harris Technologies (NYSE:LHX) 주식

L3Harris Technologies

L3Harris Technologies provides products primarily for the command, control, communications, computers, intelligence, surveillance, and reconnaissance, or C4ISR, market. The firm produces uncrewed aerial vehicles, sensors, and avionics, provides military and commercial training services, and maintains the us Federal Aviation Administration's communications infrastructure. In July 2023, the company acquired Aerojet Rocketdyne, a key supplier of rocket motors used in the space industry and to propel munitions.

Government

SPACE

Politics

Tech

억만장자 일론 머스크가 도널드 트럼프 대통령과 친분이 있다는 사실은 그의 막대한 부에 도움이 될 수 있다. 새로운 보도에 따르면 머스크의 스페이스X가 미국 연방항공청(FAA)으로부터 잠재적인 자금을 지원받을 수 있다고 한다.

일론 머스크의 스페이스X, 트럼프 2기 동안 스타링크의 FAA 계약 확보할 수 있을까?

Equities

News

Markets

ETFs

$BTC

ABNB

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

ARKF

ARKG

ARKK

ARKW

COIN

월요일(3일) 캐시 우드의 아크 인베스트는 에어비앤비(NASDAQ:ABNB), 코인베이스 글로벌(NASDAQ:COIN), 템퍼스AI(NASDAQ:TEM), AR

아크 인베스트: 템퍼스AI·에어비앤비 매수, 암호화폐 시장 하락 속 코인베이스 매수

General

PLTR

화요일(25일) 보도에 따르면, 일론 머스크가 이끄는 정부효율부(DOGE)에서 20명이 넘는 공무원들이 사직했다. 이들은 필수적인 공공 인프라를 해체하는 일에 참여하기를 거부했기 때문이다. 

머스크의 정부효율부 직원들 집단 사직 &#34;중요한 공공 서비스 해체에 반대&#34;...백악관 &#34;항의나 소송에 굴하지 않을 것&#34;

L3Harris Technologies Inc

Macro Economic Events

Econ #s

Economics

USA API Weekly Crude Oil Stock 1.455M Barrel Draw Vs 300K Barrel Draw Est.; 640K Barrel Draw Prior

LNZA

LanzaTech Expects Streamline Initiatives To Drive $30M Of Annual Cash Operating Expense Reductions

WIIM

MRNA

Moderna shares are trading higher after Stephane Bancel Disclosed a share purchase.

SCOR

comScore shares are trading higher following a Q4 revenue beat.

Insider Trades

Moderna CEO Stephane Bancel Discloses Open Market Purchase Of 160,314 Shares At Avg. Price $31.22

CrowdStrike Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) reported financial results for the fourth quarter Tuesday after the bell. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/25/03/b44125867/crowdstrike-reports-fourth-quarter-and-fiscal-year-2025-financial-results">from the report</a>.
Q4 Earnings: CrowdStrike reported fourth-quarter revenue of $1.058 billion, beating the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $1.032 billion.&nbsp;The cybersecurity company reported adjusted earnings of $1.03 per share, beating analyst estimates of 85 cents per share.
CrowdStrike has beat analyst estimates on the top and bottom lines in every quarter since going public in 2019, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue was up 25% year-over-year. Annual recurring revenue increased 23% year-over-year to $4.24 billion after the company added $224.3 million of net new ARR in the quarter.
Net cash generated from operations was $345.7 million and free cash flow came in at $239.8 million. The company ended the quarter with $4.32 billion in cash, equivalents and short-term investments.
&#8220;As businesses of all sizes rapidly adopt AI, stopping the breach necessitates cybersecurity&#8217;s AI-native platform. We are seeing strong momentum in our Next-Gen SIEM, Cloud Security, and Identity Protection businesses, surpassing&nbsp;$1.3 billion&nbsp;in combined ending ARR,&#8221; said&nbsp;George Kurtz, co-founder, president and CEO of CrowdStrike.
&#8220;With&nbsp;97%&nbsp;gross retention and accounts adopting Falcon Flex adding over&nbsp;$1 billion&nbsp;of in-quarter deal value, customers are increasingly consolidating on the Falcon platform as their AI-native SOC for today and tomorrow.&#8221;
Related Link: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44116610/investors-shouldnt-run-to-the-hills-over-tariffs-dan-ives-points-to-8-ai-stocks-to-own">Investors Shouldn&#8217;t &#8216;Run To The Hills&#8217; Over Tariffs: Dan Ives Points To 8 AI Stocks &#8216;To Own&#8217;</a>
Guidance:&nbsp;CrowdStrike expects first-quarter revenue to be between $1.1 billion and $1.106 billion versus estimates of $1.106 billion. The company anticipates first-quarter adjusted earnings of 64 cents to 66 cents per share versus estimates of 95 cents per share.
CrowdStrike also introduced full-year 2026 guidance. The company expects full-year revenue of $4.74 billion to $4.81 billion versus estimates of $4.77 billion. The company anticipates full-year adjusted earnings in the range of $3.33 to $3.45 per share versus estimates of $4.42 per share.
The soft earnings guidance appears to be weighing on shares. CrowdStrike executives will further discuss the quarter on a call with investors and analysts at 5 p.m. ET.
CRWD Price Action: <a href="https://www.benzinga.com/quote/CRWD" target="_blank" rel="noreferrer noopener">CrowdStrike shares</a> were down 5.9% after hours, trading at $366.95 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44114754/stock-market-sell-off-history-shows-sp-500-rebounds-after-big-drops">Stock Market Sell-Off: History Shows S&amp;P 500 Rebounds After Big Drops</a></li>
</ul>
Photo: Shutterstock.

Earnings

Guidance

After-Hours Center

Movers

CRWD

CrowdStrike Q4 Earnings: Revenue Beat, EPS Beat, 'Strong Momentum,' Shares Slide On Soft Guidance

ALUR

Allurion Technologies shares are trading higher after the company announced the issuance of new U.S. patents.

LanzaTech Reschedules Q4 And Full-year 2024 Earnings Call To March 31, 2025, To More Closely Align With  Filing Of Its Annual Report On Form 10-K

<ul>
<li>Net sales of between $560 million and $590 million</li>
<li>Adjusted EBITDA of between $60 million and $66 million</li>
<li>Free Cash flow of between $43 million and $50 million</li>
</ul>

Mayville Engineering Company Sees FY25 Revenue $560M-$590M Vs $604.1M Estimate

Enlivex Therapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENLV#NASDAQ">ENLV</a>, the "Company"))), a clinical-stage macrophage reprogramming immunotherapy company,&nbsp;is pleased to invite investors to a live investor webinar on March 5, 2025, at 11:00 a.m. ET to discuss the positive interim six-month data from the Phase I stage of its ongoing randomized, multi-country Phase I/II Allocetra&#x2122; trial in patients with moderate to severe knee osteoarthritis.
The exclusive event, hosted by RedChip Companies, will feature the Company's Chief Executive Officer, Oren Hershkovitz Ph.D., who will provide a detailed review of the interim results, which demonstrated a statistically significant 47.0% average reduction in reported pain (P=0.0001) and a 46% improvement in joint function at six months post-treatment. Additionally, 83% of treated patients were still considered responders to treatment at six months, which the Company believes highlights the durability and sustained efficacy of Allocetra&#x2122; as a potential breakthrough treatment for osteoarthritis. Importantly, no serious adverse events were reported, reinforcing the favorable safety profile of Allocetra&#x2122;.

Biotech

Events

ENLV

EVLV

Enlivex Therapeutics Announces Investor Webinar To Discuss Interim Data From Phase I/II Allocetra Trial In Knee Osteoarthritis On March 5, 2025, At 11:00 a.m. ET

LanzaTech Implements Strategic Measures To Scale Its Business Globally With Greater Cost Efficiency, Expects Consolidations To Reduce Workforce By Approximately 10% - 15%

BNRG

Brenmiller Energy shares are trading higher after the company reported a year-over-year increase in FY24 EPS results.

Repay Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) shares are trading lower Tuesday after multiple firms reduced their price <a href="https://www.benzinga.com/quote/RPAY/news">targets on the stock. </a>
What To Know: Canaccord Genuity analyst Joseph Vafi noted that Repay has strong free cash flow (FCF) conversion and a rich margin structure. However, the company is facing growth challenges, he added. 
The company is seeing headwinds from the runoff of political ad spending after the 2024 election cycle and client losses due to M&amp;A, he explained. 
One major customer decided to take payments in-house, which further affected Repay's revenue outlook. Without these setbacks, Vafi expects Repay to achieve mid-single-digit revenue growth this year.
Despite these issues, Vafi highlighted the company&#8217;s potential attractiveness as an acquisition target due to its differentiated embedded payments business and its partnerships with independent software vendors (ISVs). He indicated that Repay's business model could be appealing to larger payment players looking to expand their total addressable market. While he did not provide specific details, Vafi said the chances of a transaction occurring during the strategic review process appear to be &#8220;pretty good.&#8221;
Repay's fourth-quarter results showed mixed performance. Revenue increased by 3% year-over-year, while gross profit rose by 2%. The consumer payments segment declined by 5% in gross profit, while business payments grew by 60%. Vafi pointed out that Repay continues to add new customers through its direct salesforce and ISV partnerships, with 329 credit union customers and 280 software partners at the end of fourth-quarter. 
The company is also seeing growth in its accounts payable (AP) and accounts receivable (AR) automation offerings, with its supplier network expanding to over 360,000 from 333,000 in the previous quarter.
Vafi observed that while Repay has invested heavily in its software infrastructure, much of that work is now complete, and he expects capital expenditures as a percentage of revenue to decline to around 10% from the prior 12-13% range. This reduction could improve free cash flow conversion moving forward.
Price Action: Repay corporation shares were down 12.8% at $6.19 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="525" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04153848/Screenshot-2025-03-04-at-15.38.19-1024x525.png" alt="" class="wp-image-808986" style="width:448px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04153848/Screenshot-2025-03-04-at-15.38.19-1024x525.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04153848/Screenshot-2025-03-04-at-15.38.19-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04153848/Screenshot-2025-03-04-at-15.38.19-768x394.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04153848/Screenshot-2025-03-04-at-15.38.19.png 1530w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/03/44123733/firs-the-wealth-building-etf-you-need-to-achieve-financial-independence-and-retire-early">FIRS: The Wealth Building ETF You Need To Achieve Financial Independence And Retire Early</a></li>
</ul>
Image Created Via Midjourney.

RPAY

Repay Holdings Sinks 12% As Analyst Cites Customer Losses, Strategic Review Uncertainty

Stem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEM#NYSE">STEM</a>) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.19) by 63.16 percent. This is a 29.17 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $55.80 million which beat the analyst consensus estimate of $47.88 million by 16.53 percent. This is a 66.67 percent decrease over sales of $167.40 million the same period last year.

Earnings Beats

Earnings Misses

STEM

Stem Q4 EPS $(0.31) Misses $(0.19) Estimate, Sales $55.80M Beat $47.88M Estimate

The federal government spent $1.9 trillion on healthcare programs and services in 2024–the single largest category of federal spending. As <a href="https://www.benzinga.com/news/25/02/43988075/trump-has-a-plan-to-lower-gas-prices-experts-discuss-potential-backlashes">President Donald Trump</a>'s budget proposal makes its way to the Senate after clearing the House on Feb. 25, many are concerned how his plans will affect healthcare spending.&nbsp;
As healthcare policy and budgets take center stage in the United States, it can be helpful to shed light on where these funds are spent and how they impact Americans.&nbsp;
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
</ul>
<h2 class="wp-block-heading">Healthcare Spending in the Federal Budget</h2>
Recent data from KFF reveals that healthcare spending made up about 27% of federal spending in 2024. To put that in perspective:
<ul>
<li>Social Security accounted for 21%</li>
<li>National defense and interest payments on the debt each took up 13%</li>
</ul>
Most <a href="https://www.benzinga.com/personal-finance/24/12/42712291/438-billion-in-savings-and-335000-lives-what-it-would-cost-the-u-s-to-implement-universal-health-care">federal healthcare funding</a> supports health insurance programs, tax subsidies, and discretional health initiatives. More than 80% of the spending supported programs like Medicare, Medicaid, and employer-sponsored healthcare insurance.&nbsp;
Trending: Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.
<h2 class="wp-block-heading">Where Does the $1.9 Trillion Go?&nbsp;</h2>
Federal healthcare spending goes toward several important programs:&nbsp;
<ul>
<li>Medicare (36%): The program mainly supports adults aged 65 and older and accounts for the largest portion of federal healthcare spending. In 2024, about $839 billion was spent on Medicare. </li>
<li><a href="https://www.benzinga.com/personal-finance/25/02/43901103/medicaid-faces-880-billion-cuts-but-trump-says-social-security-is-safe">Medicaid</a> and CHIP (25%): These programs, which cover low-income individuals and families, received about $584 in federal funding. </li>
<li>Employer-based Health Coverage (17%): Employers receive tax subsidies for sponsoring healthcare coverage. These subsidies cost the government roughly $384 billion in 2024. </li>
<li>Affordable Care Act Subsidies (5%): Tax credits for healthcare premiums in the ACA Marketplace accounted for about $111 billion. </li>
<li>Veterans' Health and Other Discretionary Spending (8%): Discretionary spending covered veterans&#8217; hospital and medical care ($128 billion), funding for the National Institutes of Health ($45.5 billion), and Centers for Disease Control and Prevention programs ($8.8 billion).</li>
<li>Global Health Initiatives (4%): This includes international health assistance programs through the U.S. Department of State and the <a href="https://www.benzinga.com/tech/25/02/43781034/bill-gates-hopes-elon-musk-will-rethink-slashing-usaid-their-work-is-something-every-taxpayer-would-be-proud-of">U.S. Agency for International development</a>.</li>
</ul>
Trending: The average 401(k) balance soars to a record-breaking high – <a href="https://www.benzinga.com/money/average-401k-balances-soars-to-record-high">Here's how to know if your nest egg is keeping pace.</a>
<h2 class="wp-block-heading">Mandatory vs. Discretionary Spending</h2>
Most <a href="https://www.benzinga.com/personal-finance/25/02/43420762/us-health-care-ranks-last-among-wealthy-nations-study-reveals-despite-highest-spending-people-have-lower-than-average-life-expectancies">healthcare spending</a> (about 70%) is mandatory, meaning it's set by existing laws rather than annual budget negotiations. Programs like Medicare, Medicaid, and ACA subsidies fall into this category.
The remaining portion—discretionary spending—is approved annually by Congress. This includes funding for veterans' healthcare, medical research, and disease prevention efforts. In 2024, discretionary healthcare spending totaled $247 billion.
<h2 class="wp-block-heading">How Healthcare Funding Decisions Impact Access</h2>
Decisions about where healthcare dollars go have a big impact on coverage and access to services. When lawmakers consider cuts to healthcare programs, they look at how these changes will affect patients, healthcare providers, and the economy.
See Also: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
For instance, if Medicaid were cut, we could see a rise in the number of uninsured Americans. Lawmakers have already stated that they would oppose any budget proposals that could harm such critical programs. Reductions in Medicare reimbursements could also hurt hospitals and other healthcare providers.
Tax subsidies for employer-sponsored insurance keep costs lower for businesses, allowing them to offer healthcare coverage to employees. Adjustments to these subsidies could impact the millions of Americans who receive insurance through their workplace.&nbsp;
<h2 class="wp-block-heading">Why It Matters</h2>
Understanding how the government spends on healthcare helps taxpayers, policymakers, and consumers navigate potential changes. With ongoing debates over spending and tax policy, any shift in federal healthcare funding could ripple through the economy, affecting insurance coverage, healthcare access, and affordability.
As discussions continue, staying informed about these issues can help Americans prepare for changes that might impact their healthcare costs and options.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
<li><a href="https://www.benzinga.com/money/millionaires-never-earned-six-figures-according-to-dave-ramsey">69% of Millionaires Never Earned A Six-Figure Salary – Here Are 2 Things They Do To Get Their First $1 Million, According To Dave Ramsey</a></li>
</ul>

Personal Finance

Breaking Down The Federal Government's $1.9 Trillion Healthcare Spending: Where The Money Goes And Why It Matters

Amphenol (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) has outperformed the market over the past 20 years by 9.35% on an annualized basis producing an average annual return of 17.5%. Currently, Amphenol has a market capitalization of $76.36 billion. 
Buying $100 In APH: If an investor had bought $100 of APH stock 20 years ago, it would be worth $2,505.71 today based on a price of $63.05 for APH at the time of writing.
<h3>Amphenol's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741123811_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Amphenol Stock In The Last 20 Years

Brenmiller Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNRG#NASDAQ">BNRG</a>) reported quarterly losses of $(1.29) per share. This is a 74.15 percent increase over losses of $(4.99) per share from the same period last year.

Brenmiller Energy FY EPS $(1.29) Up From $(4.99) YoY

Brenmiller FY24 Cash And Cash Equivalents $4.13M Up From $3.21M YoY

Box, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) released its fourth-quarter results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/25/03/b44125541/box-reports-fourth-quarter-and-fiscal-2025-financial-results">details from the report.&nbsp;</a>
The Details: Box reported quarterly earnings of 42 cents per share which met the analyst consensus estimate. Quarterly revenue came in at $280 million which beat the analyst consensus estimate of $279.42 million and is an increase over revenue of $262.87 million from the same period last year.
For the fourth quarter, Box reported:
<ul>
<li>Remaining performance obligations of $1.466 billion, up 12%, or 14% on a constant currency basis.</li>
<li>Billings of $398.6 million, up 5%, or 7% on a constant currency basis. Billings were impacted by a 150 basis point headwind from unfavorable foreign exchange rates, compared to its prior expectation of an 80 basis point headwind.</li>
<li>Record non-GAAP gross profit of $226.4 million, or 81% of revenue, up from $206.1 million, or 78.4% of revenue.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/earnings/25/03/44110273/trump-tariffs-will-raise-prices-within-days-target-ceo-says">Trump Tariffs Will Raise Prices &#8216;Within Days,&#8217; Target CEO Says</a>
&#8220;Fiscal 2025 was a pivotal year for Box,&#8221; said Aaron Levie, CEO of Box. &#8220;We delivered our strongest set of AI-powered innovations and launched Enterprise Advanced, integrating the full capabilities of our platform into one solution.&#8221; 
&#8220;Early customer adoption highlights that customers are choosing Box to power intelligent metadata extraction from documents, automate workflows and dashboards with Box Apps, customize Box AI with the AI Studio, power complete business processes with Box Sign, Forms and Doc Gen, and so much more,&#8221; Levie added. 
Outlook: Box sees first quarter earnings of 25 cents to 26 cents, versus the 43-cent estimate, and revenue in a range of $274 million to $275 million, versus the $279.5 million estimate.
BOX Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Box shares are down 8.7% after hours at $30.56 Tuesday.  
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying">Markets Tank After Trump Confirms More Tariffs: Here&#8217;s What Wall Street Is Saying</a></li>
</ul>
Image: Shutterstock

Box Shares Fall After Q4 Results, Weak Q1 Guidance

Stem shares are trading higher after the company reported better-than-expected Q4 sales results.

Press Releases

US Army Awards L3Harris Nearly $300 Million for Resilient Communications Program

L3Harris Technologies Reports Fourth Quarter and Full-Year 2024 Results, Initiates 2025 Guidance

US Air Force Completes First Flight of L3Harris Viper Shield Electronic Warfare System

L3Harris Launches New Technology to Control Autonomous Swarms

L3Harris to Present at Upcoming Investor Conference

Integration of Emerging Technologies for Military Drone Market Presenting a Significant Growth Opportunity

L3Harris Breaks Ground on Solid Rocket Motor 'Factories of the Future' in Arkansas

Shield AI and L3Harris Team for Breakthrough in Autonomy

MAXAR SPACE SYSTEMS Successfully Delivers Tranche 1 Tracking Layer Spacecraft to L3Harris

Comments

L3Harris Technologies

뉴스

파트너 / 기고자

벤징가 글로벌